Viewing Study NCT05138159


Ignite Creation Date: 2025-12-24 @ 2:54 PM
Ignite Modification Date: 2025-12-27 @ 5:01 PM
Study NCT ID: NCT05138159
Status: UNKNOWN
Last Update Posted: 2021-11-30
First Post: 2021-11-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Donafenib Plus S-1 in Treating Patients With Metastatic Pancreatic Cancer After Chemotherapy With Nab-paclitaxel Plus Gemcitabine Regimen
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module